Medical Marijuana Program Connection

APRIL 12, 2023

® (Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage biopharmaceutical company developing groundbreaking therapies for. BALTIMORE, MD–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc.® Read More

Therapy 52

Therapy Pharmaceutical Clinical Trials Business 52

LifeCannMD

FEBRUARY 27, 2024

How Medical Marijuana Is Changing Lives with Crohn’s Disease Medical Marijuana is a great treatment option for battling Crohn’s Disease, a chronic inflammatory bowel condition that affects millions worldwide. We offer same-day approvals for your Florida Medical Marijuana card.

Marijuana 59

Marijuana Clinical Trials Treatment Therapy 59

MMJ Recs

APRIL 1, 2024

In recent years, the spotlight on CBD (cannabidiol) within medical marijuana has intensified, with researchers and medical professionals delving deeper into its potential therapeutic benefits. Medical Marijuana and CBD: What You Need to Know When discussing CBD, it’s essential to address its relationship with medical marijuana.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

CannaMD

AUGUST 26, 2020

A new review published by scientific journal, Pharmacology Biochemistry and Behavior , has found that marijuana cannabinoid, CBD, is a “promising” therapy for treating cocaine dependence. Reach out to CannaMD ‘s board-certified physicians to learn how medical marijuana can help! mice/rats). Get Started.

Therapy 98

Therapy CBD Research and Development Treatment 98

CannaMD

MAY 12, 2021

Smoke marijuana, get the munchies. It’s a favorite cliche of stoner parodies — but one that doesn’t do justice to the potential benefits of medical marijuana for the treatment of eating disorders. It therefore stands to reason that therapies addressing anxiety and OCD might have a positive effect on eating disorders.

Marijuana 119

Marijuana Therapy Conditions Food 119

FloridaMarijuana.net

AUGUST 15, 2018

While PTSD can be treated with therapies and pharmaceutical medications, those are not always successful and additional treatments are necessary. Veterans will not be denied benefits because of marijuana use and Veterans are encouraged to speak to their physicians about medical marijuana. Get your Florida Medical Marijuana Card.

Treatment 182

Treatment Marijuana Research and Development Therapy 182

Cannabis Law Report

APRIL 21, 2022

The availability of larger quantities of cGMP-compliant MDMA will facilitate ongoing clinical trials and provide for future therapeutic use following anticipated regulatory approvals. in each of the four validation trials with an acceptable yield, which is a noteworthy accomplishment. MEDIA CONTACT .

Clinical Trials 52

Clinical Trials Research and Development Therapy Media 52

CannaMD

MAY 25, 2021

In recent years, research has revealed that two of marijuana’s two major cannabinoids — THC and CBD — can interact with the human endocannabinoid system to influence bone healing and regeneration. These findings might indicate that cannabis therapies with a higher CBD content would prove more beneficial for bone healing and regrowth.

Marijuana 111

Marijuana Research and Development Clinical Trials THC 111

The Joint Blog

NOVEMBER 4, 2019

Researchers were from the Mayo Clinic. The study found that 58% of physicians agree that “medical cannabis was a legitimate medical therapy.” ” The study concludes: “Providers generally believe that medical cannabis is a legitimate medical therapy. A majority (>?50%) Conclusions.

Therapy 42

Therapy Clinical Trials Conditions Patients 42

Cannabis Law Report

MAY 31, 2022

Two approaches apply to commercial operations—the traditional medical path and the emerging non-medical state-regulated path, while the other two paths are better seen as non-commercial—underground therapy and religious use. 2022 Active FDA Clinical Trials and State-Regulated Systems. Active FDA Regulated Clinical Trials*.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

Cannabis Law Report

APRIL 27, 2022

Marijuana Moment reports. MDMA-assisted therapy has already shown incredible results in the stage three clinical trials for individuals suffering from severe PTSD,” Ginal told committee members. “I The bipartisan and bicameral legislation is being sponsored by Reps. John Cooke (R) and Joann Ginal (D).

Clinical Trials 52

Clinical Trials Legalization Therapy Food 52

LifeCannMD

FEBRUARY 1, 2022

As a result, people are starting to explore medical marijuana for obsessive-compulsive disorder instead. In this article, you’ll learn why and how medical marijuana is effective for treating OCD. Prescription Medicines Vs. Marijuana and OCD. There are two traditional ways to address OCD besides just medical marijuana.

Marijuana 98

Marijuana Clinical Trials Patients Therapy 98

SpeedWeed

SEPTEMBER 17, 2021

million to assess the efficacy of Multidisciplinary Association for Psychedelic Studies (MAPS) MDMA-assisted therapy to treat traumatic brain injury (TBI). Wesana is a serious, thoughtful and ethical company engaged in the development of psychedelic-assisted therapy. Lately, MAPS research zeroed in on MDMA-assisted therapy for PTSD.

Clinical Trials 53

Clinical Trials Research and Development Therapy Treatment 53

TheAnswerPage

JANUARY 11, 2022

Are you able to answer your patients’ medical marijuana questions? During my tenure, I have found the medical marijuana educational gap to be one of the most significant educational gaps that impacts a very broad range of healthcare providers. million medical marijuana patients nationwide.

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

JUNE 24, 2022

Marijuana Moment reports. The leader of the New Jersey Senate filed a bill on Thursday that would legalize the possession, home cultivation and gifting of psilocybin mushrooms for adults 21 and older—with provisions that give adults even more freedoms for the psychedelic than are afforded under the state’s current marijuana laws.

Clinical Trials 52

Clinical Trials Legalization Research and Development Therapy 52

Canna Care Docs

OCTOBER 3, 2023

Natural plant therapy , and cannabis specifically, has been studied for its effectiveness in alleviating and treating many of these physiological and emotional symptoms that come into play with a terminal illness. One study from the Journal of Clinical Oncology examined the efficacy of cannabinoids in appetite stimulation.

Chronic Pain 105

Chronic Pain Clinical Trials Patients Cannabinoids 105

MMJ Recs

NOVEMBER 20, 2023

In recent years, the medical community and the public have shown a growing interest in the therapeutic potential of medical marijuana. This article delves into the science behind medical marijuana, focusing on cannabinoids, the active compounds found in the cannabis plant, and their remarkable therapeutic effects.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

NewsMunchies

NOVEMBER 12, 2021

In clinical trials, psilocybin (the psychoactive substance in mushrooms) has shown tremendous promise in treating severe depression, post-traumatic stress disorder, and other mental illnesses. As such, magic mushroom therapy offers hope. Additional clinical trials underway in the U.S. In a typical year in the U.S.

Clinical Trials 90

Clinical Trials Therapy Decriminalization DEA 90

CannaMD

JUNE 2, 2021

A new study indicates that a significant number of persons suffering from Parkinson’s disease use medical marijuana for symptom relief. The goal of the study was to gain a better understanding of not only the frequency of marijuana use by those suffering from Parkinson’s, but also their motivations for use and their experiences.

Patients 105

Patients Clinical Trials Treatment Research and Development 105

Cannabis Law Report

AUGUST 30, 2021

It’s considered a breakthrough therapy,” Dr McTaggart said. “With COVID-19 right now, I think there’s never been a better time to start looking for therapies for mental health.” But, like medicinal marijuana, Dr McTaggart said that would change, in line with other countries. Psychedelic renaissance.

Clinical Trials 105

Clinical Trials Collective Therapy Treatment 105

Cannabis Law Report

JUNE 29, 2021

Synergetic Press and the Multidisciplinary Association for Psychedelic Science (MAPS) are pleased to announce they have entered into a copublishing relationship effective May 1, 2021 which will greatly expand the availability of education about psychedelics and psychedelic therapy.

Therapy 90

Therapy Research and Development Clinical Trials Education 90

Cannabis Law Report

DECEMBER 9, 2021

“We believe it is the responsibility of psychedelic-therapy companies to provide material support to the life-changing research being done in the space, which has made our work possible. MAPS is sponsoring the most advanced psychedelic therapy research in the world: Phase 3 clinical trials of MDMA-assisted therapy for PTSD.

Research and Development 52

Research and Development Therapy Clinical Trials Treatment 52

TheAnswerPage

MARCH 9, 2020

EXPERIMENTAL pain studies indicate that cannabinoids may be an effective therapy for acute and chronic pain. Have the results of CLINICAL studies also shown that cannabinoids are effective at alleviating acute and chronic pain? In addition, pre-operative and peri-operative marijuana use may increase post-operative perceived pain.

Chronic Pain 52

Chronic Pain Clinical Trials Therapy Cannabinoids 52

Cannabis Law Report

MAY 29, 2022

FDA granted Breakthrough Therapy designation for Spravato in 2013 and ultimately approved it for adults who have not responded to treatment after trying other antidepressant medications. More recently, MDMA therapy has inched closer to FDA approval. Clinical Trials and Human Subject Protections.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JUNE 21, 2021

retains CRO Sante Cannabis to conduct clinical trials in psilocybin therapies. via Marijuana Moment. Entheon Biomedical Corp. CSE: ENBI) announces agreement to acquire Lobo Genetics Inc. Press Release. Wake Network Inc. Press Release. AREV Nanotec Brands Inc. Press Release. Mydecine Innovations Group Inc.

Clinical Trials 66

Clinical Trials Research and Development Therapy Pharmaceutical 66

Cannabis Life Network

DECEMBER 16, 2022

Health Canada continues to drag its feet on magic mushroom therapy. ” “Currently, the best way for patients to access psilocybin is through participation in a clinical trial,” the statement said. .” They’ve granted a few Canadians this right, but others have been waiting over 400 days for a reply.

Therapy 99

Therapy Clinical Trials Access Patients 99

The Joint Blog

JANUARY 31, 2021

According to a new study published in the Journal of Medical Case Reports , the daily use of high-CBD (cannabidiol) marijuana extracts is associated with improvements in the behavioral symptoms related to autism spectrum disorder (ASD). The individual was given very low-doses of marijuana extracts, no larger than 0.2 ml twice daily.

Epilepsy 62

Epilepsy Extraction Research and Development Clinical Trials 62

MMJ Recs

DECEMBER 28, 2023

In recent years, a significant shift has occurred in the perception of medical marijuana, transforming it from a controversial substance to a recognized and, in some places, a legal form of medical treatment. Medical marijuana, however, has emerged as a potential alternative.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

Greencamp

FEBRUARY 2, 2019

These medications are combined in what’s known as HAART (highly active antiretroviral therapy). Even though these pharmaceuticals slow down the progression and lessen the quantity of the virus in a patient’s body, many sufferers experience severe pain from antiretroviral therapy. Cannabis as a palliative aid for HIV patients.

Marijuana 110

Marijuana Therapy Cannabinoids Patients 110

Veriheal

MAY 26, 2022

Dedicated to “redefining what’s possible,” the 501(c)(3) organization has provided 1:1 support and resources to over 69,000 clients as they navigated plant-powered cannabinoid therapy. RoC also works to increase patients’ access to medical cannabis by helping U.S. Today’s science is confirming what many cultures have known for centuries.

Advocacy 96

Advocacy Patients Clinical Trials Education 96

PrestoDoctor

OCTOBER 11, 2023

In recent years, there has been growing interest in exploring alternative therapies for individuals with ASD. Derived from the cannabis plant, CBD is a non-psychoactive compound that does not produce the “high” typically associated with marijuana. One such area of focus is the use of CBD-rich cannabis.

CBD 52

CBD Research and Development Clinical Trials Treatment 52

MMJ Recs

NOVEMBER 30, 2023

In recent years, there has been growing interest in exploring alternative treatment options, and one that has gained attention is medical marijuana (MMJ). Medical Marijuana for Epilepsy Treatment Medical marijuana, often referred to as MMJ, is a term used to describe the use of cannabis and its derivatives for therapeutic purposes.

Epilepsy 105

Epilepsy Treatment Patients Strains 105

Otherside Farms

JANUARY 14, 2019

Marijuana has been used for centuries for medicinal purposes; however, it has earned a bad name due to its widespread abuse as an addictive substance. This has pushed into oblivion the positive impact of marijuana seeds and its extracts on various body systems, including the cardiovascular system, the brain and the reproductive system.

Clinical Trials 49

Clinical Trials Strains Therapy Medicine 49

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD. “Patients will benefit from cGMP-quality therapies in an accessible and efficient format.”. . Most recently the FDA awarded MMJ International Holdings ?Orphan

DEA 66

DEA Clinical Trials THC Research and Development 66

NORML

JANUARY 18, 2019

House lawmakers introduced The Medical Cannabis Research Act of 2019 (HR 601), to facilitate federally-approved clinical trials involving cannabis. Another great way to stay up to date is Marijuana Moment’s daily newsletter, which you can subscribe to HERE. Additionally, a bipartisan coalition of U.S. Your Highness, Carly.

Legislation 166

Legislation Decriminalization Access Therapy 166

Cannabis Law Report

SEPTEMBER 23, 2022

Founded in 1986, MAPS is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. MAPS has earned both the Guidestar Platinum Seal of Transparency and a 4-Star Rating from Charity Navigator.

Decriminalization 52

Decriminalization Advocacy Research and Development Education 52

Cannabis Law Report

OCTOBER 9, 2021

Under HB 1959 , which was formally filed with 19 cosponsors on Wednesday, the state Department of Health would authorize at least two entities to “plant, grow and cultivate natural psilocybin mushroom product solely for use in the clinical studies of psilocybin.”. Read more at Marijuana Moment. House of Representatives.

Therapy 52

Therapy Clinical Trials Treatment Legislation 52